CN108785772A - A kind of Blood index purifier - Google Patents
A kind of Blood index purifier Download PDFInfo
- Publication number
- CN108785772A CN108785772A CN201810607671.2A CN201810607671A CN108785772A CN 108785772 A CN108785772 A CN 108785772A CN 201810607671 A CN201810607671 A CN 201810607671A CN 108785772 A CN108785772 A CN 108785772A
- Authority
- CN
- China
- Prior art keywords
- blood
- index
- adsorbent
- purifier
- purifier according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008280 blood Substances 0.000 title claims abstract description 83
- 210000004369 blood Anatomy 0.000 title claims abstract description 83
- 238000000502 dialysis Methods 0.000 claims abstract description 30
- 238000001179 sorption measurement Methods 0.000 claims abstract description 20
- 239000006096 absorbing agent Substances 0.000 claims abstract description 19
- 239000003463 adsorbent Substances 0.000 claims description 21
- 239000007788 liquid Substances 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 16
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims description 10
- WHGYBXFWUBPSRW-FOUAGVGXSA-N beta-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO WHGYBXFWUBPSRW-FOUAGVGXSA-N 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 9
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 8
- 229920000858 Cyclodextrin Polymers 0.000 claims description 7
- 239000001116 FEMA 4028 Substances 0.000 claims description 7
- 235000011175 beta-cyclodextrine Nutrition 0.000 claims description 7
- 229960004853 betadex Drugs 0.000 claims description 7
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 claims description 5
- 229940109239 creatinine Drugs 0.000 claims description 5
- 238000007385 chemical modification Methods 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 3
- 230000008859 change Effects 0.000 claims description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims description 3
- 239000010452 phosphate Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 238000004132 cross linking Methods 0.000 claims description 2
- 239000002808 molecular sieve Substances 0.000 claims description 2
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 abstract description 22
- 238000005516 engineering process Methods 0.000 abstract description 15
- 239000003053 toxin Substances 0.000 abstract description 14
- 231100000765 toxin Toxicity 0.000 abstract description 14
- 238000000746 purification Methods 0.000 abstract description 9
- 239000000385 dialysis solution Substances 0.000 abstract description 6
- 230000004087 circulation Effects 0.000 abstract description 3
- 238000011161 development Methods 0.000 abstract description 3
- 230000000192 social effect Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 6
- 239000002699 waste material Substances 0.000 description 6
- 238000001631 haemodialysis Methods 0.000 description 5
- 230000008929 regeneration Effects 0.000 description 5
- 238000011069 regeneration method Methods 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 239000010800 human waste Substances 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 238000013475 authorization Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical class C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
Abstract
The present invention relates to a kind of Blood index purifier, which is directly separated blood using dialysis separator device, and the weak solution of the small flow separated is after absorber fixes toxin, then the Blood index purification techniques that is directly mixed with the concentrated solution of larger flow.The device eliminates the dialysis fluid circulation in conventional blood adsorption and purification technology, it is directly separated using blood, small flow weak solution adsorption and purification technology, device compact provides new technical thought for the development of portable blood clearing machine, and economy, social effect are huge.
Description
Technical field
The present invention relates to a kind of Blood index purifiers, more particularly to a kind of to be directly separated blood using dialyzer, point
The weak solution of the small flow come is separated out to inhale after absorber fixes toxin, then with the blood that the concentrated solution of larger flow directly mixes
Attached purification techniques belongs to apparatus for purifying blood technical field.
Background technology
Haemodialysis is a kind of external dialysis treatment for filtering toxin from the blood of patient using haemodialysis control unit.At present
Most of haemodialysis control units generally comprise computer, fluid pump, blood lines, dialysate lines, dialyzer and for discharging
The tapping line of dialysis solution.Blood passes through the dialyzer for including semi-permeable membrane in haemodialysis control unit.Semi-permeable membrane is by side
Blood is separated with the dialysis solution at another layer.Dialyzer removes waste, toxin and excessive water, purified blood from blood
Liquid returns to human body.Waste product and toxin are transferred to from blood in dialysis solution by semi-permeable membrane, are used in single dialysis treatment
Dialyzate about 90-120 liters, then directly abandon or processing after discharge.Obviously, a large amount of used dialyzate can increase dialysis
Cost.Since the needs that dialyzate can also include various concentration pass through the substance for spreading and being introduced into blood flow, such as drug, grape
Sugar, these components when passing through dialyzer can not possibly completely into blood, thus also can some be discharged with discarded dialyzate；
In addition, also having some components beneficial to human body to enter discarded dialyzate by semi-permeable membrane in blood.Above-mentioned various factors is led
It causes the cost of haemodialysis to increase, waste increase, also can cause environmental pollution.Therefore, many dialyzate recycling profits are produced
With technology, typical technology is as follows：
A kind of dialysate regeneration system for portable human dialysis of Chemica Technologies Inc. of U.S. application, in
State's number of patent application is 200480038117.3, and the request for data of PCT application is PCT/US2004/043546
(2004.12.22) was authorized, Authorization Notice No. CN1897993B, core technology flow diagram on February 08th, 2012
As shown in Fig. 1.The key technology of the patent uses a kind of dialysate regeneration room 14, can selectively retain toxin and repel
The toxin trap of the cation of selection, wherein the ion selection urase that the toxin trap includes ion selection barrier is fixed
Activated carbon fiber.The advantages of technology is that flow is simple, reasonable for structure, easy to carry.But it also has the shortcomings that certain：Due into
It is big to enter the low thus required adsorbent adsorption area of toxin concentration in the dialyzate of dialysate regeneration room, the suction of unit volume
Attached dose of adsorption efficiency is relatively low, and adsorbent inventory is more.
Chinese patent (application number：201510106383.5) a kind of dialysate regeneration device is provided, using reverse osmosis group
Part and electric catalysis reactor based on BDD electrodes utilize the very wide potential window of the electric catalysis reactor based on BDD electrodes and low
Adsorption capacity, oxidation process is very efficient, effectively can convert and remove waste product and toxin in dialyzate, device it is continuous
Runnability is good.But its also have the shortcomings that it is certain, if electric catalysis reactor may following components generate catalytic action, cause to become
Property or generate harmful substance, such as penetrate in the blood of human body Hubeiwan of dialyzate, dialyzate and be not fully utilized
Needs substance (such as drug or glucose) in blood is introduced by diffusion.
Therefore above-mentioned technology how is solved the problems, such as, using few use or even without the blood purification skill of dialyzate
Art becomes one of hot subject of the area research.
Invention content
The present invention is in order to solve the problems existing in the prior art, to be directly separated blood using dialysis separator device, isolate
The weak solution of the small flow come is after absorber fixes toxin, then the Blood index directly mixed with the concentrated solution of larger flow is net
Change technology.The device eliminates the dialysis fluid circulation in conventional blood adsorption and purification technology, is directly separated using blood, is small
Flow weak solution adsorption and purification technology, device compact provide new technology think of for the development of portable blood clearing machine
Road.
The purpose of the present invention is what is realized by following measures：
A kind of Blood index purifier, it is characterised in that：
The Blood index purifier includes dialysis separator 32, absorber 37：Blood of human body is drawn pipeline 30 and is drawn
The blood gone out is sent into dialysis separator 32 after the supercharging of blood booster pump 31, and it is molten to isolate higher concentration from dialysis separator 32
Liquid and lower concentration solutions, wherein higher concentration solution come out from the dope side 32-1 of dialysis separator 32, through dope outlet
Line 33 is sent into mixer 34, and lower concentration solutions come out from the thin liquid side 32-2 of dialysis separator 32, through thin liquid booster pump 35, dilute
Solution pipeline 36 is sent into absorber 37, and thin liquid outlet line 38 is sent into mixer 34 after the solution that absorber 37 comes out is purified,
Human body 40 is returned to through blood return tube line 39 through 34 mixed blood of mixer, to form blood of human body adsorption cleaning cycle
Process.
The dialysis separator 32 includes shell, dope side 32-1, semipermeable membrane, thin liquid side 32-2.
Adsorbent is housed in the absorber 37.
The adsorbent includes specific adsorption material and/or non-specific adsorption material.
The specific adsorption material includes but not limited to beta-cyclodextrin, the compound of beta-cyclodextrin group, β-ring paste
Compound that compound, beta-cyclodextrin chemical modification after essence crosslinking are modified, beta-cyclodextrin is through the modified chemical combination of chemical modification
The high molecular material that object is polymerized, the n-alkyl chain group containing 6 carbon or more compound in any one or it
Between arbitrary proportion combination.
The non-specific adsorption material includes any one or appointing between them at least in activated carbon, molecular sieve
Meaning ratio combines.
The adsorbent is using the organosilicon material compatible with blood of human body as carrier.
The adsorbent is for adsorbing urea nitrogen.
The adsorbent is for adsorbing creatinine.
The adsorbent is for adsorbing phosphate.
Semipermeable membrane in the dialysis separator 32 is used to detach small molecule waste product and the toxin in blood, including
But it is not limited to urea nitrogen, creatinine and other small organic human waste molecules, water.
The Blood index purifier is equipped with necessary blood anticoagulant and facility is added.
The Blood index purifier is equipped with the facility of necessary replacement absorber and adsorbent.
The Blood index purifier is equipped with necessary detection instrument, valve and control system etc..
When needing, it is equipped with ultrafilter, extra moisture is isolated from Blood index purifier.
The unaccounted technical characteristic of the present invention is carried out mating using the ripe prior art.
The present invention has the following advantages that compared with prior art：
1, this Blood index purifier eliminates the dialysis fluid circulation of conventional blood purification techniques, and device is small and exquisite tight
It gathers, new possible technique thinking is provided for the development of portable blood clearing machine；
2, the substance such as drug, glucose etc. being introduced by diffusion in blood flow is needed, mixer can be directly added into, is entered
Human body efficiently utilizes；
3, using dialysis separator, absorber combination purification technology, the weak solution come out from dialysis separator uses small stream
Measure adsorption cleaning toxin, sorbing material in absorber effectively avoided to be in direct contact with macromolecular substances in blood, eliminate because
This issuable harm；The small-molecule substance loss beneficial to human body is effectively avoided caused by traditional dialyzate cycle.
Description of the drawings
Fig. 1 is a kind of dialysate regeneration system flow diagram for portable human dialysis.
Fig. 2 is a kind of Blood index purifier schematic diagram of the present invention.
In Fig. 2：30- blood draws pipeline；31- blood booster pumps；32- dialysis separators；32-1- dopes side；32-2-
Thin liquid side；33- dope outlet lines；34- mixers；35- thin liquid booster pumps；36- weak solution pipelines；37- absorbers；38- is net
Thin liquid outlet line after change；39- blood reflux pipelines；40- human bodies.
Specific implementation mode
Below in conjunction with the drawings and specific embodiments, present invention is further described in detail.
Embodiment 1：
As shown in Fig. 2, a kind of Blood index purifier that embodiment uses：
The Blood index purifier includes dialysis separator 32, absorber 37：Blood of human body draws what pipeline 30 was drawn
Blood through blood booster pump 31 supercharging after, be sent into dialysis separator 32, from dialysis separator 32 isolate higher concentration solution and
Lower concentration solutions, wherein higher concentration solution come out from the dope side 32-1 of dialysis separator 32, through dope outlet line 33
It is sent into mixer 34, lower concentration solutions come out from the thin liquid side 32-2 of dialysis separator 32, through thin liquid booster pump 35, weak solution
Pipeline 36 is sent into absorber 37, and thin liquid outlet line 38 is sent into mixer 34 after the solution that absorber 37 comes out is purified, through mixed
34 mixed blood of clutch returns to human body 40 through blood return tube line 39, is circulated throughout to form blood of human body adsorption cleaning
Journey.
The dialysis separator 32 includes shell, dope side 32-1, semipermeable membrane, thin liquid side 32-2.
Adsorbent is housed in the absorber 37.
The adsorbent uses non-specific adsorption material.
The non-specific adsorption material includes activated carbon fibre.
The adsorbent is using the organosilicon material compatible with blood of human body as carrier.
The adsorbent is for adsorbing urea nitrogen.
The adsorbent is for adsorbing creatinine.
The adsorbent is for adsorbing phosphate.
Semipermeable membrane in the dialysis separator 32 is used to detach small molecule waste product and the toxin in blood, including
But it is not limited to urea nitrogen, creatinine and other small organic human waste molecules, water.
The Blood index purifier is equipped with necessary blood anticoagulant and facility is added.
The Blood index purifier is equipped with necessary detection instrument, valve and control system etc..
When needing, it is equipped with ultrafilter, extra moisture is isolated from Blood index purifier.
The unaccounted technical characteristic of the present invention is carried out mating using the ripe prior art.
Although the present invention has been described by way of example and in terms of the preferred embodiments, they be not for limiting the present invention, it is any to be familiar with
This field technical professional can make various simple modifications, equivalent variations without departing from the spirit and scope of the invention,
Still fall within the protection domain of technical solution of the present invention.
Claims (9)
1. a kind of Blood index purifier, it is characterised in that：
The Blood index purifier includes dialysis separator (32), absorber (37)：Blood of human body draws pipeline (30)
The blood of extraction through blood booster pump (31) supercharging after, be sent into dialysis separator (32), from dialysis separator (32) isolate compared with
Highly concentrated solution and lower concentration solutions, wherein higher concentration solution come out from the dope side (32-1) of dialysis separator (32),
It is sent into mixer (34) through dope outlet line (33), lower concentration solutions go out from the thin liquid side (32-2) of dialysis separator (32)
Come, is sent into absorber (37) through thin liquid booster pump (35), weak solution pipeline (36), the solution come out from absorber (37) is purified
Thin liquid outlet line (38) is sent into mixer (34) afterwards, is returned through blood return tube line (39) through mixer (34) mixed blood
The Huis' body (40), to form blood of human body adsorption cleaning cyclic process.
2. Blood index purifier according to claim 1, it is characterised in that：
The dialysis separator (32) includes shell, dope side (32-1), semipermeable membrane, thin liquid side (32-2).
3. Blood index purifier according to claim 1, it is characterised in that：
Adsorbent is housed in the absorber (37)；The adsorbent includes specific adsorption material and/or non-specificity
Sorbing material.
4. Blood index purifier according to claim 3, it is characterised in that：
The specific adsorption material includes the change after beta-cyclodextrin, the compound of beta-cyclodextrin group, beta-cyclodextrin crosslinking
Object, the compound that beta-cyclodextrin chemical modification is modified, beta-cyclodextrin is closed to be polymerized through the modified compound of chemical modification
High molecular material, n-alkyl chain group containing six carbon or more compound in any one or it is arbitrary between them
Ratio combines.
5. Blood index purifier according to claim 3, it is characterised in that：
The non-specific adsorption material includes any one in activated carbon, molecular sieve or the arbitrary proportion group between them
It closes.
6. Blood index purifier according to claim 3, it is characterised in that：
The adsorbent is using the organosilicon material compatible with blood of human body as carrier.
7. Blood index purifier according to claim 3, it is characterised in that：
The adsorbent is for adsorbing creatinine.
8. Blood index purifier according to claim 3, it is characterised in that：
The adsorbent is for adsorbing phosphate.
9. Blood index purifier according to claim 3, it is characterised in that：
The adsorbent is for adsorbing urea nitrogen.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810607671.2A CN108785772B (en) | 2018-06-13 | 2018-06-13 | Blood adsorption purification device |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810607671.2A CN108785772B (en) | 2018-06-13 | 2018-06-13 | Blood adsorption purification device |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN108785772A true CN108785772A (en) | 2018-11-13 |
| CN108785772B CN108785772B (en) | 2024-04-09 |
Family
ID=64087042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810607671.2A Active CN108785772B (en) | 2018-06-13 | 2018-06-13 | Blood adsorption purification device |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108785772B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11207150A (en) * | 1998-01-21 | 1999-08-03 | Terumo Corp | Liquid purifier using live bacterial and liquid purifying device |
| US20010041892A1 (en) * | 1998-02-19 | 2001-11-15 | Nxstage Medical, Inc. | Hemofiltration system including ultrafiltrate purification and re-infusion system |
| US20100268156A1 (en) * | 2007-11-06 | 2010-10-21 | Walter Milacek | Medical device in the form of a catheter for supplying and/or removing fluid into and/or from, especially body cavities, especially the pleural cavity |
| US20140190886A1 (en) * | 2013-01-09 | 2014-07-10 | Medtronic, Inc. | Recirculating dialysate fluid circuit for blood measurement |
| CN209075641U (en) * | 2018-06-13 | 2019-07-09 | 上海健康医学院 | A kind of Blood index purification device |
-
2018
- 2018-06-13 CN CN201810607671.2A patent/CN108785772B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11207150A (en) * | 1998-01-21 | 1999-08-03 | Terumo Corp | Liquid purifier using live bacterial and liquid purifying device |
| US20010041892A1 (en) * | 1998-02-19 | 2001-11-15 | Nxstage Medical, Inc. | Hemofiltration system including ultrafiltrate purification and re-infusion system |
| US20100268156A1 (en) * | 2007-11-06 | 2010-10-21 | Walter Milacek | Medical device in the form of a catheter for supplying and/or removing fluid into and/or from, especially body cavities, especially the pleural cavity |
| US20140190886A1 (en) * | 2013-01-09 | 2014-07-10 | Medtronic, Inc. | Recirculating dialysate fluid circuit for blood measurement |
| CN209075641U (en) * | 2018-06-13 | 2019-07-09 | 上海健康医学院 | A kind of Blood index purification device |
Also Published As
| Publication number | Publication date |
|---|---|
| CN108785772B (en) | 2024-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9713668B2 (en) | Multi-staged filtration system for blood fluid removal | |
| EP1993631B1 (en) | Regeneratable filter for extracorporal treatment of liquids containing particles and use thereof | |
| JPH0451185B2 (en) | ||
| CN108310503A (en) | A kind of Almightiness type plasma purification system based on centrifugal separation plasma method | |
| CN105209088A (en) | Device for removing protein-bound toxins from blood plasma | |
| CN205073379U (en) | Plasma exchange adsorbs filters clean system | |
| CN201123923Y (en) | Mixed type artificial liver system capable of for curing multiple-organ dysfunctional syndrome | |
| CN209075641U (en) | A kind of Blood index purification device | |
| CN108785772A (en) | A kind of Blood index purifier | |
| CN209475257U (en) | A kind of dialyzate high-efficient purification reclaiming system | |
| CN205515729U (en) | Blood purifying device and system | |
| CN209475256U (en) | A kind of dialyzate high-efficient purification regenerative system | |
| CN106377812B (en) | A kind of plasma circulation acceleration purification system | |
| CN108785773B (en) | Efficient purifying and regenerating system for dialysate | |
| CN108785774B (en) | Efficient purifying and recycling system for dialysate | |
| CN209052516U (en) | A kind of water treatment facilities for family hemodialysis instrument | |
| US12011691B2 (en) | Fluid treatment method, cycle treatment device and system | |
| RU93276U1 (en) | EXTRACORPORAL BLOOD CLEANING DEVICE | |
| CN203139198U (en) | Simple blood purifier | |
| CN114225141A (en) | Adsorption filtration purification system for plasmapheresis treatment | |
| CN206492050U (en) | A kind of plasma circulation accelerates cleaning system | |
| CN208552669U (en) | A kind of Almightiness type plasma purification system based on centrifugal separation plasma method | |
| CN213884485U (en) | Blood purification system with blood waste adsorption function | |
| CN205360107U (en) | Blood purifying device and blood clean system | |
| GB2083761A (en) | A combination sorbent, dialyser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |